How to Buy Gyre Therapeutics Stock

Gyre Therapeutics Inc

Gyre Therapeutics, Inc. is a pharmaceutical company dedicated to discovering, advancing, and bringing to market small-molecule drugs that target inflammation and fibrosis in various organs.

Gyre Therapeutics stock last closed at $5.82, down 0.68% from the previous day, and has decreased 27.52% in one year. It has overperformed other stocks in the Biotechnology industry by 0.44 percentage points. Gyre Therapeutics stock is currently +6.99% from its 52-week low of $5.44, and -38.22% from its 52-week high of $9.42.

As of Jun 16, 2026, there are 97.03M shares of GYRE outstanding. The market cap of GYRE is $564.70M. In the past 24 hours, 75,000 GYRE shares were traded.

How to Buy Gyre Therapeutics Stock

Not sure how to invest in Gyre Therapeutics stock? Here's how.

  1. Figure out where to buy Gyre Therapeutics stock: You need to pick a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Gyre Therapeutics stock.
  2. Sign up for a brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've selected.
  3. Deposit funds into your investment account: Choose your payment method and add your info.
  4. Research Gyre Therapeutics stock: The Gyre Therapeutics ticker symbol is GYRE. Is Gyre Therapeutics stock a good investment? Should you buy shares of GYRE? How do GYRE's underlying business fundamentals look? Do top analysts think Gyre Therapeutics is a good buy? Why has GYRE's stock price moved recently? (Hint: Our stock research tools can help you evaluate if GYRE is a good stock to buy).
  5. Place your GYRE trade: Decide if you will purchase GYRE shares at the current market price or use a limit order to purchase GYRE stock at a given price.
  6. Get key alerts regarding your investment in GYRE: Create a watchlist to keep track of your position in Gyre Therapeutics stock.

Step 1: Figure out where to buy Gyre Therapeutics stock

You need a brokerage account to access the NASDAQ market and buy GYRE stock.

A brokerage account is an investment account that enables you to buy and sell a variety of investments, including stocks, bonds, mutual funds, and ETFs.

Our preferred brokerage: eToro

Based on our analysis, eToro is the best brokerage. Here's why:

  • You can invest in stocks with 0% commissions: Invest without commissions.
  • Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
  • Access to world markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
  • Social investing: eToro boasts a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
  • Security: eToro is a regulated and licensed brokerage platform.
  • Buy other financial assets: Such as ETFs and cryptos.

Get $10 towards your purchase of shares by signing up for an account with eToro today. This offer is only for US users.

Open eToro Account
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.

Step 2: Sign up for a brokerage account

Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to invest in GYRE today.

How to Set Up a New Account on eToro

  1. Click here to get started.
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
  2. Provide your personal data to open a new brokerage account.
  1. Submit your data by hitting the "Create Account" button.
  2. Get started with eToro today
    eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 3: Deposit funds into your investment account

Now that you have opened your account on the best app for stock investing, you can securely and quickly fund your account:

Check out the walkthrough below to see the process of depositing funds into your new investment account.

Get started with eToro today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

Step 4: Research Gyre Therapeutics stock

After you have figured out the best place to buy Gyre Therapeutics stock, it's absolutely critical to research their stock prior to buying, so you actually comprehend the risk as well as the upside.

Gyre Therapeutics shares at a glance

GYRE Price
$5.82
1w %
-5.06%
1y %
-27.52%
5y %
-91.04%
P/E
-72.75x
P/B
5.57x
P/S
4.54x
PEG
N/A
Revenue
$117.05M
Earnings
-$6.36M
Fore. Rev. Growth
12.41%
Fore. Earn. Growth
N/A
Market Cap
$564.70M
Next Earnings
N/A
Next Dividend
N/A

Fundamentals of GYRE

WallStreetZen was designed to help part-time investors perform more in-depth fundamental analysis in less time.

You can see all of the due diligence checks on GYRE's stock page.

Is GYRE stock undervalued or overvalued?

Analysts use many financial metrics, analyses, models, and charts to gauge GYRE's intrinsic value.

Using relative valuations metrics:

  • GYRE may be overvalued based on its P/B ratio of 5.57x, relative to Biotechnology industry P/B ratio of 4.86x

You can do additional valuation analysis on GYRE's stock here.

A look at GYRE Cashflows and Balance Sheet

Passed Financial Due Diligence Checks:

  • GYRE's operating cash flow of $4.32M allows it to safely service it's debt of $823.00k.
  • There are more short-term assets than long-term liabilities on the GYRE balance sheet.
  • GYRE has a low debt to equity ratio of 0.25.
  • There are more short-term assets than short-term liabilities on the GYRE balance sheet.

Failed Financial Due Diligence Checks:

  • GYRE earnings of -$2.09M is not enough to cover its interest payments.
  • GYRE profit margin has gone down from 7.2% to -5.4% in the past year.
  • Total GYRE debt is higher than 5 years ago, relative to shareholder equity.

You can dive deeper into what analysts are saying on the Gyre Therapeutics stock forecast page.

GYRE Technical Indicators

SMA10
6
SMA20
5.97
SMA50
6.89
SMA100
7.33
SMA200
7.51
MACD
-0.27
MACD Signal
-0.31
MACD Histogram
0.04
RSI
39.58
Stochastic %K
35.25
Stochastic %D
40.44
StochRSI %K
65.32
StochRSI %D
71.27

Is GYRE Making Money?

Last year, GYRE revenue was $117.05M. During the past five year, GYRE's revenue has gone up by 80.86% per year. This was faster than the Biotechnology industry average of 32.16%.

Dig into GYRE's earnings and revenue performance here.

Who is buying/selling GYRE?

Over the past year, executives and large shareholders at GYRE have sold more shares than they have bought.

Weiguo Ye, Chief Operating Officer of GYRE, was the latest GYRE insider to buy. They bought $2,100.00 worth of GYRE shares on Jun 11, 2026.

Learn more about who owns GYRE stock here.

Can I rely on GYRE as an income stream?

No, Gyre Therapeutics doesn't provide an income stream by paying out dividends.

What do other investors have to say about GYRE?

One of the major reasons eToro is our top-rated brokerage is because of its social trading community.

Click below to learn what other traders have to say.

Step 5: Place your GYRE trade

There are two primary options:

  • Market order: A market order is an order to buy or sell a security at the best available price.
    Market orders are generally fine.
  • Limit order: A limit order enables you to buy or sell a security at a specific price (or better).
    If you want to ensure you're buying or selling at a specific dollar amount, place a limit order.

Hit the Open button and your broker will place your order.

If you want more help with buying stocks on eToro, click the helpful video below:

Open eToro Account

Step 6: Get key alerts regarding your investment in GYRE

Now that you own some GYRE stock, you'll want to keep up with your company.

Put GYRE on a watchlist to get the latest updates about your GYRE stock.

GYRE Feed

How to Buy Stock in Gyre Therapeutics

To reiterate, here are the 6 steps to buy Gyre Therapeutics stock:

  1. Figure out where to buy Gyre Therapeutics stock
  2. Sign up for a brokerage account
  3. Deposit funds into your investment account
  4. Research Gyre Therapeutics stock
  5. Place your GYRE trade
  6. Get key alerts regarding your investment in GYRE

If you require a brokerage account, eToro is our recommended venue.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

If you would like to track your investment in Gyre Therapeutics, get started below.

NASDAQ: GYRE
$5.82-0.04 (-0.68%)
Updated Jun 16, 2026
Open eToro Account
Your capital is at risk.
NASDAQ: GYRE
$5.82-0.04 (-0.68%)
Updated Jun 16, 2026
Open eToro Account
Your capital is at risk.

FAQ

How much does it cost to buy one Gyre Therapeutics share?

As of Jun 16, 2026, it costs $5.82 to buy one share of Gyre Therapeutics stock.

Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.344 shares of GYRE.

Get Started with eToro Today
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.

What is the best way to buy Gyre Therapeutics stock?

One way to place an order for Gyre Therapeutics stock is with a brokerage account.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.